Registration filing
Logotype for OneMedNet Corporation

OneMedNet (ONMD) Registration filing summary

Event summary combining transcript, slides, and related documents.

Logotype for OneMedNet Corporation

Registration filing summary

16 Sep, 2026

Company overview and business model

  • Operates as a healthcare software company specializing in digital medical image management, exchange, and sharing, with a focus on regulatory-grade imaging Real World Data (iRWD) for life sciences, pharma, and AI markets.

  • Provides solutions that de-identify, curate, and deliver clinical imaging data from a federated network of over 1,400 healthcare sites, supporting research, regulatory submissions, and product development.

  • Transitioned from its BEAM image exchange platform to focus on iRWD, targeting pharmaceutical, device, and AI companies seeking high-quality, curated imaging data.

  • Business model includes fixed-fee contracts for iRWD data delivery and subscription-based revenue for legacy BEAM platform, with a shift toward data brokerage as the primary revenue stream.

  • Strategic partnerships and private placements have expanded its data network and capital base, supporting growth and innovation in the Real World Evidence market.

Financial performance and metrics

  • Reported net losses of $10.1 million in 2024 and $33.8 million in 2023, with an accumulated deficit of $101.6 million as of December 31, 2024.

  • Revenue for 2024 was $0.64 million, down 37% from 2023, driven by the planned discontinuation of the BEAM platform and a strategic shift to iRWD sales.

  • Gross margin was negative in both 2024 and Q1 2025, reflecting high costs relative to revenue during the transition period.

  • As of March 31, 2025, cash and cash equivalents were $0.1 million, with $0.8 million in Bitcoin holdings; liquidity remains a significant concern.

  • Auditor's report includes a going concern warning due to recurring losses, negative cash flows, and insufficient liquidity for the next 12 months.

Use of proceeds and capital allocation

  • Proceeds from warrant exercises (up to $139 million if fully exercised) are intended for working capital and general corporate purposes.

  • Recent private placements and PIPE financings have been used to purchase Bitcoin, settle liabilities, and fund operations.

  • Additional capital raises are planned to support ongoing operations and growth initiatives.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more